| Fairhaven Vision Clinic Pllc | |
|
1207 Old Fairhaven Pkwy, Bellingham, WA 98225-7411 | |
| (360) 733-1190 | |
| (360) 734-1306 |
| Full Name | Fairhaven Vision Clinic Pllc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1207 Old Fairhaven Pkwy, Bellingham, Washington |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356413439 | NPI | - | NPPES |
| 616790001 | Other | WA | GROUP HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OD00000910 (Washington) | Primary |
| Provider Name | Richard L Klinnert |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1891873832 PECOS PAC ID: 8123919222 Enrollment ID: I20040810001018 |
News Archive
Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has entered into agreements to acquire substantially all of the assets of Blue Water Surgical Centre Ltd., Blue Water Rejuvenation Inc., Blue Water Diagnostics Ltd. and Windsor Endoscopy Centre Ltd., along with 75% of the issued and outstanding securities of the London Scoping Centre.
Cook Medical's controlled-release esophageal stent fully covered in silicone has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making available yet another advanced solution from Cook Medical, the only full-line supplier of endoscopic devices.
Kaiser Health News staff writer Jordan Rau reports: Adding another piece to the argument that some hospitals are making huge profits from insurers, a new study finds great differences in hospital rates, with San Francisco the most expensive of eight areas that were examined (Rau, 11/18).
Researchers have developed ‘nano-sized' probes built from DNA that can seek and destroy cancer cells, leaving healthy cells untouched. These ‘nanorobots' release their drug payload only when they reach and identify their target and are believed to improve many treatments for disease.
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
› Verified 5 days ago
| Provider Name | Andrew L Barber |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1588735377 PECOS PAC ID: 8426107962 Enrollment ID: I20090513000033 |
News Archive
Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has entered into agreements to acquire substantially all of the assets of Blue Water Surgical Centre Ltd., Blue Water Rejuvenation Inc., Blue Water Diagnostics Ltd. and Windsor Endoscopy Centre Ltd., along with 75% of the issued and outstanding securities of the London Scoping Centre.
Cook Medical's controlled-release esophageal stent fully covered in silicone has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making available yet another advanced solution from Cook Medical, the only full-line supplier of endoscopic devices.
Kaiser Health News staff writer Jordan Rau reports: Adding another piece to the argument that some hospitals are making huge profits from insurers, a new study finds great differences in hospital rates, with San Francisco the most expensive of eight areas that were examined (Rau, 11/18).
Researchers have developed ‘nano-sized' probes built from DNA that can seek and destroy cancer cells, leaving healthy cells untouched. These ‘nanorobots' release their drug payload only when they reach and identify their target and are believed to improve many treatments for disease.
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
› Verified 5 days ago
| Provider Name | James Santoro |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1578799292 PECOS PAC ID: 6406002104 Enrollment ID: I20120813000470 |
News Archive
Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has entered into agreements to acquire substantially all of the assets of Blue Water Surgical Centre Ltd., Blue Water Rejuvenation Inc., Blue Water Diagnostics Ltd. and Windsor Endoscopy Centre Ltd., along with 75% of the issued and outstanding securities of the London Scoping Centre.
Cook Medical's controlled-release esophageal stent fully covered in silicone has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making available yet another advanced solution from Cook Medical, the only full-line supplier of endoscopic devices.
Kaiser Health News staff writer Jordan Rau reports: Adding another piece to the argument that some hospitals are making huge profits from insurers, a new study finds great differences in hospital rates, with San Francisco the most expensive of eight areas that were examined (Rau, 11/18).
Researchers have developed ‘nano-sized' probes built from DNA that can seek and destroy cancer cells, leaving healthy cells untouched. These ‘nanorobots' release their drug payload only when they reach and identify their target and are believed to improve many treatments for disease.
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fairhaven Vision Clinic Pllc 1207 Old Fairhaven Pkwy, Bellingham, WA 98225-7411 Ph: (360) 733-1190 | Fairhaven Vision Clinic Pllc 1207 Old Fairhaven Pkwy, Bellingham, WA 98225-7411 Ph: (360) 733-1190 |
News Archive
Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has entered into agreements to acquire substantially all of the assets of Blue Water Surgical Centre Ltd., Blue Water Rejuvenation Inc., Blue Water Diagnostics Ltd. and Windsor Endoscopy Centre Ltd., along with 75% of the issued and outstanding securities of the London Scoping Centre.
Cook Medical's controlled-release esophageal stent fully covered in silicone has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making available yet another advanced solution from Cook Medical, the only full-line supplier of endoscopic devices.
Kaiser Health News staff writer Jordan Rau reports: Adding another piece to the argument that some hospitals are making huge profits from insurers, a new study finds great differences in hospital rates, with San Francisco the most expensive of eight areas that were examined (Rau, 11/18).
Researchers have developed ‘nano-sized' probes built from DNA that can seek and destroy cancer cells, leaving healthy cells untouched. These ‘nanorobots' release their drug payload only when they reach and identify their target and are believed to improve many treatments for disease.
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
› Verified 5 days ago
Dr. Rajbir Kaur Khehra, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4540 Cordata Pkwy Ste 103, Bellingham, WA 98226 Phone: 360-676-8663 Fax: 360-676-8682 | |
Bryan T Redick, OD Optometrist Medicare: Medicare Enrolled Practice Location: 302 36th St, Bellingham, WA 98225 Phone: 360-363-0360 Fax: 360-363-0160 | |
Aleksey Shkurat Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 1303 Cornwall Ave, Bellingham, WA 98225 Phone: 360-647-0421 Fax: 360-647-0469 | |
Dr. Cam My Ly, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4125 Arctic Ave, Bellingham, WA 98226 Phone: 360-812-7015 Fax: 360-812-7019 | |
Vision Plus Optometrist Medicare: Medicare Enrolled Practice Location: 2520 James St, Bellingham, WA 98225 Phone: 360-733-7393 Fax: 360-722-7785 | |
Dr. Hannah Margaret Joyner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 720 Birchwood Ave, Bellingham, WA 98225 Phone: 360-733-1720 Fax: 360-733-0109 | |
Rhonda Swanson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4420 Meridian St, Kulshan Eye Care, Bellingham, WA 98226 Phone: 360-647-0212 Fax: 360-647-2212 |